Cigna Group (CI)

As of 14 August 2026, short interest in CI is 5,240,030 shares, down 938,392 shares over the last month. Over the last 48 readings it ranged from 2,453,026 shares (31 July 2025) to 7,333,399 shares (15 June 2026). At the reported average volume of 2.2M shares a day that is 2.4 days to cover.

<iframe src="https://xoomar.com/embed/stocks/ci" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

As of 11 September 2026, the short share of CI volume is 52.7%, down 5.8 points over the last five sessions. Over the last 52 readings it ranged from 18.6% (27 July 2026) to 65.0% (8 September 2026). The latest reading is 9.2 points above the 30-session average of 43.5%, on 385K shares reported.

As of 28 July 2026, the fails-to-deliver balance in CI is 53 shares, down 47 shares over the last settlement date. Over the last 30 readings it ranged from 4 shares (6 April 2026) to 156,016 shares (22 June 2026). The latest reading sits at the bottom of that range.

Insiders at CI reported 3 open-market sells worth $6.3M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Neville Everett (See Remarks) on 2026-09-03.

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

3 Form 144 notices on file for CI worth $6.3M at the prices reported; 3 in the last 90 days worth $6.3M. Latest: Neville Everett filed on 2026-09-03 to sell 617 shares ($175K) from 2026-09-03.

10 of the 30 tracked managers held CI at their latest 13F, $1.53B in total at quarter-end prices. Two Sigma Investments is the largest at $501.5M (0.4% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 3 cut.

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

In Q2 2026 (quarter ended 2026-06-30) Cigna Group reported revenue of $71.67B, up 6.7% from the same quarter a year earlier, and net income of $1.66B (6.29 diluted EPS). In FY 2025 it generated $9.60B of operating cash flow and spent $3.62B on buybacks and $1.61B on dividends. As of 2026-06-30, cash was $6.30B against $2.79B of debt.

Quarterly, last 8 quarters

Fiscal years, with buybacks and dividends

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-24 from the cover page.